Leptin, obesity and cardiovascular disease

Purpose of reviewObesity is a risk factor for cardiovascular diseases. Leptin levels are increased in obesity and leptin exhibits cardiovascular actions that may contribute to increased cardiovascular risk. We review the sympathetic, renal and vascular actions of leptin and their relevance to cardiovascular disease. Recent findingsLeptin possesses cardio-renal actions potentially contributing to obesity-related hypertension including generalized sympathoactivation. However, given that leptin resistance occurs in obesity, it has been difficult to link hyperleptinemia with hypertension. One possibility is that leptin resistance is confined to the metabolic effects of leptin, with preservation of its sympathoexcitatory actions. Other mechanisms may contribute to the pressor effects of leptin. For instance, angiotensin II induces leptin generation. Leptin also potentiates the pressor effect of insulin. Therefore, interactions between angiotensin II and insulin with leptin could have deleterious cardiovascular effects in obesity. Additionally, leptin appears to stimulate vascular inflammation, oxidative stress and hypertophy. These actions may contribute to the pathogenesis of hypertension, atherosclerosis, and left ventricular hypertrophy. SummaryThe potential actions of leptin in the pathophysiology of cardiovascular complications of obesity are diverse, despite evidence of leptin resistance to its metabolic actions. However, most information about cardiovascular actions of leptin derives from in-vitro and animal studies. Future research in humans is widely awaited.

[1]  L. Kirshenbaum,et al.  The Obesity-Associated Peptide Leptin Induces Hypertrophy in Neonatal Rat Ventricular Myocytes , 2003, Circulation research.

[2]  L. Wold,et al.  Abrogated Leptin-Induced Cardiac Contractile Response in Ventricular Myocytes Under Spontaneous Hypertension: Role of JAK/STAT Pathway , 2002, Hypertension.

[3]  K. Chayama,et al.  Leptin causes nitric-oxide independent coronary artery vasodilation in humans. , 2003, Hypertension research : official journal of the Japanese Society of Hypertension.

[4]  A. Mark,et al.  Does leptin cause functional peripheral sympatholysis? , 2001, American journal of hypertension.

[5]  Hypertension in obesity and the leptin receptor gene locus. , 2000, The Journal of clinical endocrinology and metabolism.

[6]  Y. Giudicelli,et al.  Sexual Dimorphism in Cafeteria Diet-Induced Hypertension Is Associated with Gender-Related Difference in Renal Leptin Receptor Down-Regulation , 2003, Journal of Pharmacology and Experimental Therapeutics.

[7]  R. Surwit,et al.  Role of leptin in fat regulation , 1996, Nature.

[8]  N. Moustaid‐Moussa,et al.  Angiotensin II increases leptin secretion by 3T3-L1 and human adipocytes via a prostaglandin-independent mechanism. , 2002, The Journal of nutrition.

[9]  F. Triposkiadis,et al.  Elevated plasma immunoreactive leptin levels preexist in healthy offspring of patients with essential hypertension. , 1999, American heart journal.

[10]  J. Henriksen,et al.  Elevated circulating leptin levels in arterial hypertension: relationship to arteriovenous overflow and extraction of leptin. , 2000, Clinical science.

[11]  B. Winters,et al.  Reduction of obesity, as induced by leptin, reverses endothelial dysfunction in obese (Lep(ob)) mice. , 2000, Journal of applied physiology.

[12]  T. Cole,et al.  Influence of Leptin on Arterial Distensibility: A Novel Link Between Obesity and Cardiovascular Disease? , 2002, Circulation.

[13]  A. Mark,et al.  Receptor-mediated regional sympathetic nerve activation by leptin. , 1997, The Journal of clinical investigation.

[14]  T. Olsson,et al.  Plasma leptin levels are associated with abnormal fibrinolysis in men and postmenopausal women , 1999, Journal of internal medicine.

[15]  A. Mark,et al.  Selective Resistance to Central Neural Administration of Leptin in Agouti Obese Mice , 2002, Hypertension.

[16]  N. Chu,et al.  Obesity, leptin and blood pressure among children in Taiwan: the Taipei Children's Heart Study. , 2001, American journal of hypertension.

[17]  Z. Pausova,et al.  Gender-specific correlates of leptin with hypertension-related phenotypes in African Americans. , 2002, American journal of hypertension.

[18]  O. B. Jones,et al.  Chronic cardiovascular and renal actions of leptin during hyperinsulinemia. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.

[19]  C. Zoccali,et al.  Gender-dependent differences in plasma leptin in essential hypertension. , 2000, American journal of hypertension.

[20]  G. Renier,et al.  Leptin increases lipoprotein lipase secretion by macrophages: involvement of oxidative stress and protein kinase C. , 2003, Diabetes.

[21]  G. Dibona.  Sympathetic nervous system and the kidney in hypertension , 2002, Current opinion in nephrology and hypertension.

[22]  M. Lane,et al.  Leptin regulates proinflammatory immune responses. , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  E. Jackson,et al.  Human leptin has natriuretic activity in the rat. , 1997, The American journal of physiology.

[24]  A. Siani,et al.  Plasma leptin and blood pressure in men: graded association independent of body mass and fat pattern. , 2003, Obesity research.

[25]  K. Chayama,et al.  Leptin causes vasodilation in humans. , 2002, Hypertension research : official journal of the Japanese Society of Hypertension.

[26]  Y. Miyazaki,et al.  High plasma immunoreactive leptin level in essential hypertension. , 1997, American journal of hypertension.

[27]  J. Bełtowski,et al.  Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia. , 2003, Atherosclerosis.

[28]  L. Wold,et al.  Leptin Attenuates Cardiac Contraction in Rat Ventricular Myocytes: Role of NO , 2000, Hypertension.

[29]  Arya M. Sharma,et al.  Bound leptin and sympathetic outflow in nonobese men. , 2003, The Journal of clinical endocrinology and metabolism.

[30]  A. Mark,et al.  The concept of selective leptin resistance: evidence from agouti yellow obese mice. , 2002, Diabetes.

[31]  R. Freeman,et al.  Renal effects of leptin in normotensive, hypertensive, and obese rats. , 1998, American journal of physiology. Regulatory, integrative and comparative physiology.

[32]  A. Mark,et al.  Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. , 2002, Journal of hypertension.

[33]  J. Connell,et al.  Endothelial dysfunction as a possible link between C-reactive protein levels and cardiovascular disease. , 2000, Clinical science.

[34]  J. Hare,et al.  Disruption of Leptin Signaling Contributes to Cardiac Hypertrophy Independently of Body Weight in Mice , 2002, Circulation.

[35]  G. Yoshino,et al.  C-reactive protein in young, apparently healthy men: associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol. , 2003, Metabolism: clinical and experimental.

[36]  H. Chiba,et al.  Elevated serum leptin concentrations in women with components of multiple risk factor clustering syndrome. , 2000, Journal of atherosclerosis and thrombosis.

[37]  S. Gardiner,et al.  Regional haemodynamic effects of recombinant murine or human leptin in conscious rats , 2000, British journal of pharmacology.

[38]  L. Cassis,et al.  Differential effects of local versus systemic angiotensin II in the regulation of leptin release from adipocytes. , 2004, Endocrinology.

[39]  G. Paolisso,et al.  Plasma leptin level is associated with myocardial wall thickness in hypertensive insulin-resistant men. , 1999, Hypertension.

[40]  R. Freeman,et al.  Effects of renal denervation on the sodium excretory actions of leptin in hypertensive rats. , 2000, Kidney international.

[41]  T. Olsson,et al.  High Leptin Levels Are Associated with Stroke , 2003, Cerebrovascular Diseases.

[42]  L. Bouter,et al.  Leptin and variables of body adiposity, energy balance, and insulin resistance in a population-based study. The Hoorn Study. , 1999, Diabetes care.

[43]  Y. Kaneda,et al.  Leptin Induces Mitochondrial Superoxide Production and Monocyte Chemoattractant Protein-1 Expression in Aortic Endothelial Cells by Increasing Fatty Acid Oxidation via Protein Kinase A* , 2001, The Journal of Biological Chemistry.

[44]  K. Hosoda,et al.  Pathophysiological role of leptin in obesity-related hypertension. , 2000, The Journal of clinical investigation.

[45]  Jennifer L. Mitchell,et al.  Does Leptin Stimulate Nitric Oxide to Oppose the Effects of Sympathetic Activation? , 2001, Hypertension.

[46]  A. Distler,et al.  Relationship between angiotensinogen, leptin and blood pressure levels in young normotensive men , 1998, Journal of hypertension.

[47]  R. Westrick,et al.  Effect of leptin on arterial thrombosis following vascular injury in mice. , 2002, JAMA.

[48]  N. Sattar,et al.  Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS) , 2001, Circulation.

[49]  A. Mark,et al.  Leptin Acts in the Central Nervous System to Produce Dose-Dependent Changes in Arterial Pressure , 2001, Hypertension.

[50]  S. Henderson,et al.  Neointimal Formation After Endovascular Arterial Injury Is Markedly Attenuated in db/db Mice , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[51]  T. Olsson,et al.  Leptin is associated with increased risk of myocardial infarction , 1999, Journal of internal medicine.

[52]  G. Frühbeck.  Pivotal role of nitric oxide in the control of blood pressure after leptin administration. , 1999, Diabetes.

[53]  C. Klanke,et al.  Genetic markers at the leptin (OB) locus are not significantly linked to hypertension in African Americans. , 1998, Hypertension.

[54]  I. Godsland,et al.  Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[55]  Jennifer L. Mitchell,et al.  Role of Corticotrophin-Releasing Factor in Effects of Leptin on Sympathetic Nerve Activity and Arterial Pressure , 2001, Hypertension.

[56]  M. Esler,et al.  Interactions Between Leptin and the Human Sympathetic Nervous System , 2003, Hypertension.

[57]  G. Paolisso,et al.  Plasma leptin concentrations and cardiac autonomic nervous system in healthy subjects with different body weights. , 2000, The Journal of clinical endocrinology and metabolism.

[58]  S. Koschnick,et al.  Leptin-dependent platelet aggregation and arterial thrombosis suggests a mechanism for atherothrombotic disease in obesity. , 2001, The Journal of clinical investigation.

[59]  G. Lembo,et al.  Cooperation Between Insulin and Leptin in the Modulation of Vascular Tone , 2003, Hypertension.

[60]  V. Somers,et al.  Leptin interacts with heart rate but not sympathetic nerve traffic in healthy male subjects , 2001, Journal of hypertension.

[61]  John E. Hall,et al.  Chronic Cardiovascular and Renal Actions of Leptin: Role of Adrenergic Activity , 2002, Hypertension.

[62]  Huiqing Lu,et al.  Intracerebroventricular Leptin Increases Lumbar and Renal Sympathetic Nerve Activity and Blood Pressure in Normal Rats , 1997, Diabetes.

[63]  M. Cartellieri,et al.  No Evidence for Leptin as an Independent Associate of Blood Pressure in Childhood and Juvenile Obesity , 2000, Journal of pediatric endocrinology & metabolism : JPEM.

[64]  C. Chen,et al.  Leptin concentrations in relation to overall adiposity, fat distribution, and blood pressure in a rural Chinese population , 2001, International Journal of Obesity.

[65]  L. Fratta,et al.  Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway. , 2002, Diabetes.

[66]  A. Mark,et al.  Differential modulation of leptin-induced sympathoexcitation by baroreflex activation , 2002, Journal of hypertension.

[67]  O. B. Jones,et al.  Inhibition of NO Synthesis Enhances Chronic Cardiovascular and Renal Actions of Leptin , 2001, HYPERTENSION.

[68]  M. Yokoyama,et al.  Leptin stimulates rat aortic smooth muscle cell proliferation and migration. , 2001, The Kobe journal of medical sciences.

[69]  David Cohen,et al.  African Americans , 2021, Race Talk in a Mexican Cantina.

[70]  I. Maruyama,et al.  Effect of Leptin in Platelet and Endothelial Cells: Obesity and Arterial Thrombosis , 2000, Annals of the New York Academy of Sciences.

[71]  M. Adamczak,et al.  Relationship between plasma renin profile and leptinaemia in patients with essential hypertension , 2000, Journal of Human Hypertension.

[72]  A. Mark,et al.  Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. , 1999, Hypertension.

[73]  D. Morgan,et al.  Effects of leptin on insulin sensitivity in normal rats. , 1997, Endocrinology.

[74]  L. Fratta,et al.  Leptin induces direct vasodilation through distinct endothelial mechanisms. , 2000, Diabetes.

[75]  A. von zur Mühlen,et al.  Free and protein bound leptin are distinct and independently controlled factors in energy regulation , 2000, Diabetologia.

[76]  F. Parhami,et al.  Leptin Enhances the Calcification of Vascular Cells: Artery Wall as a Target of Leptin , 2001, Circulation research.

[77]  A. Marciniak,et al.  Human leptin administered intraperitoneally stimulates natriuresis and decreases renal medullary Na+, K+-ATPase activity in the rat -- impaired effect in dietary-induced obesity. , 2002, Medical science monitor : international medical journal of experimental and clinical research.

[78]  J. Hall,et al.  Chronic leptin infusion increases arterial pressure. , 1998, Hypertension.

[79]  T. Ogihara,et al.  Leptin gene polymorphism is associated with hypertension independent of obesity. , 2002, The Journal of clinical endocrinology and metabolism.